GlassScriptPhysician profile
David L Lau
NPI 1982868287
$819.05
in general payments reported to CMS, 2019-2025
8 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $190 · 2023: $119 · 2024: $150 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $321.13 | 2022-2025 | Endurant Iis, Hawkone, Valiant Captivia |
| W. L. Gore & Associates, INC. | $236.44 | 2024-2025 | Gore Excluder Iliac Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.78 | 2022 | |
| Boston Scientific Corporation | $74.86 | 2024-2025 | Eluvia, Ranger |
| Bolton Medical INC | $35.17 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Cook Medical LLC | $32.10 | 2025 | Zenith Alpha |
| Abiomed | $26.50 | 2024 | Impella |
| Stryker Corporation | $14.07 | 2025 | Clottriever Bold Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.